Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Nov 6;17:4875–4885. doi: 10.2147/IDR.S480520

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024 Yılmaz et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Survival analysis of prognostic factors. (A) Effect of initial response to treatment at day 3 on survival. Patients who were non-responsive to the treatment had strikingly higher mortality rates. (B) Effect of CURB-65 scores at the presentation on survival. Patients with CURB-65 score equal to or above 2 had more unfavorable outcome. (C) Effect of PSI class at the presentation on survival. Patients with PSI class 5 comparing to others had poorer prognosis. (D) Effect of tachypnea at the presentation on survival. Patients with respiratory rates ≥22 had more unfavorable outcome.